Andrew Hamer

Technik-/Wissenschafts-/F&E-Leiter bei CARDIOL THERAPEUTICS INC.

Vermögen: 627 176 $ am 31.05.2024

62 Jahre

Health Technology

Consumer Services

Aktive Positionen von Andrew Hamer

Unternehmen	Position	Beginn	Ende
CARDIOL THERAPEUTICS INC.	Technik-/Wissenschafts-/F&E-Leiter	29.03.2021	-

Unternehmen	Position	Beginn	Ende
AMGEN INC.	Corporate Officer/Principal	01.01.2018	01.03.2021
CAPRICOR THERAPEUTICS, INC.	Technik-/Wissenschafts-/F&E-Leiter	22.11.2013	30.07.2015
Capricor, Inc. Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013.	Technik-/Wissenschafts-/F&E-Leiter	01.11.2013	-

University of Otago

Undergraduate Degree

International

Operativ

Chief Tech/Sci/R&D Officer	3
Undergraduate Degree	1
Corporate Officer/Principal	1

Sektoral

Health Technology	5
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	3
CAPRICOR THERAPEUTICS, INC.	Health Technology
CARDIOL THERAPEUTICS INC.	Health Technology
AMGEN INC.	Health Technology

Private Unternehmen	1
Capricor, Inc. Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013.	Health Technology

Private Unternehmen

Health Technology